BRIEF: ImmuneOnco to raise $45 million via share placement at 13% discount
Innovative drug developer ImmuneOnco (1541.HK) announced on Thursday that it plans to place 24.2 million new shares, representing about 5.61% of its enlarged share capital, to raise HK$351 million ($45…
BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Wednesday that cumulative orders for its core products, including laparoscopic, orthopedic, and vascular intervention surgical robots, surpassed 170 units as of…
BRIEF: Heavily oversubscribed CF PharmTech triples in Hong Kong trading debut
Shares of pharmaceutical manufacturer CF PharmTech Inc. (2652.HK) roared out of the gate in their Hong Kong trading debut on Wednesday, opening up 219% before giving back some of the…
BRIEF: Xuanzhu Biopharma launches IPO to raise $100 million
Xuanzhu Biopharmaceutical Co., Ltd. (2575.HK), spun off from Sihuan Pharma (0460.HK), launched its IPO on Monday, aiming to sell 67.3 million shares for HK$11.60 each to raise HK$780 million ($100…
BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
BRIEF: CF PharmTech to raise $77 million in Hong Kong IPO
Pharmaceutical manufacturer CF PharmTech Inc. (2652.HK) on Friday launched its Hong Kong IPO, seeking to raise about HK$601 million ($77 million) by selling 41.2 million shares for HK$14.75 apiece. The…
BRIEF: GenFleet shares double in heavily oversubscribed IPO
Shares of biopharmaceutical firm GenFleet Therapeutics (Shanghai) Inc. (2595.HK) opened up 116% in their Hong Kong trading debut on Friday, and held on to the gains to close up more…
